Patient preferences for treatment of metastatic melanoma.

Aim: To investigate patient preferences for clinical attributes of first-line metastatic melanoma treatments.

Materials & Methods: A discrete-choice experiment and best-worst scaling exercise were used to assess relative preferences for treatment attributes.

Results: The 200 survey respondents had distinct preferences.